Long Interspersed Nuclear Element 1 Hypomethylation Is a Marker of Poor Prognosis in Stage IA Non–Small Cell Lung Cancer
Tóm tắt
Purpose: Global hypomethylation and the hypermethylation of gene promoter regions are common events in tumor DNA. The aim of this study was to evaluate the prognostic significance of both global hypomethylation and gene promoter hypermethylation in DNA from non–small cell lung cancer (NSCLC).
Experimental Design: Genomic DNA was obtained from the tumor tissue of 379 NSCLC patients who underwent surgery. Methylation levels were measured by real-time PCR following bisulfite modification of DNA and were correlated with clinicopathologic parameters and patient prognosis. Methylation of long interspersed nuclear element 1 (LINE-1) was used as a surrogate marker for global methylation. Hypermethylation of the APC, CDH13, and RASSF1 promoter regions was also evaluated.
Results: Tumor tissue showed significantly higher CDH13 and RASSF1 methylation levels compared with normal lung tissue, but lower LINE-1 methylation levels. APC, RASSF1, and LINE-1 methylation levels were significant prognostic factors in univariate analysis of an initial cohort of 234 cases. APC and LINE-1 methylation remained significant prognostic factors in multivariate analysis that included age, gender, smoking history, histologic type, and pathologic stage. LINE-1 methylation showed marginally significant prognostic value in stage IA and IB disease. Expansion of the study cohort to 364 cases revealed that LINE-1 methylation had significant prognostic value for stage IA NSCLC patients in multivariate analysis.
Conclusions: LINE-1 hypomethylation was an independent marker of poor prognosis in stage IA NSCLC. Validation of this finding in additional tumor cohorts could have clinical relevance for the management of early-stage NSCLC. Clin Cancer Res; 16(8); 2418–26. ©2010 AACR.
Từ khóa
Tài liệu tham khảo
Suzuki, 1999, Prognostic factors in clinical stage I non-small cell lung cancer, Ann Thorac Surg, 67, 927, 10.1016/S0003-4975(99)00140-X
van Rens, 2000, Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA, Chest, 117, 374, 10.1378/chest.117.2.374
Arriagada, 2004, Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer, N Engl J Med, 350, 351, 10.1056/NEJMoa031644
Kato, 2004, A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung, N Engl J Med, 350, 1713, 10.1056/NEJMoa032792
Jones, 2002, The fundamental role of epigenetic events in cancer, Nat Rev Genet, 3, 415, 10.1038/nrg816
Ehrlich, 2002, DNA methylation in cancer: too much, but also too little, Oncogene, 21, 5400, 10.1038/sj.onc.1205651
Frigola, 2005, Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer, Hum Mol Genet, 14, 319, 10.1093/hmg/ddi028
Esteller, 1999, Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients, Cancer Res, 59, 67
Palmisano, 2000, Predicting lung cancer by detecting aberrant promoter methylation in sputum, Cancer Res, 60, 5954
Battagli, 2003, Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients, Cancer Res, 63, 8695
Chen, 2005, Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene, J Natl Cancer Inst, 97, 1124, 10.1093/jnci/dji204
Tang, 2000, Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer, J Natl Cancer Inst, 92, 1511, 10.1093/jnci/92.18.1511
Kawakami, 2000, Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma, J Natl Cancer Inst, 92, 1805, 10.1093/jnci/92.22.1805
Brabender, 2001, Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival, Oncogene, 20, 3528, 10.1038/sj.onc.1204455
Maruyama, 2004, Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma, Cancer, 100, 1472, 10.1002/cncr.20144
Ota, 2006, Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis, Anticancer Res, 26, 3729
Brock, 2008, DNA methylation markers and early recurrence in stage I lung cancer, N Engl J Med, 358, 1118, 10.1056/NEJMoa0706550
Eden, 2003, Chromosomal instability and tumors promoted by DNA hypomethylation, Science, 300, 455, 10.1126/science.1083557
Gaudet, 2003, Induction of tumors in mice by genomic hypomethylation, Science, 300, 489, 10.1126/science.1083558
Roman-Gomez, 2005, Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia, Oncogene, 24, 7213, 10.1038/sj.onc.1208866
Pattamadilok, 2008, LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer, Int J Gynecol Cancer, 18, 711, 10.1111/j.1525-1438.2007.01117.x
Ogino, 2008, A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer, J Natl Cancer Inst, 100, 1734, 10.1093/jnci/djn359
Lander, 2001, Initial sequencing and analysis of the human genome, Nature, 409, 860, 10.1038/35057062
Deininger, 2003, Mobile elements and mammalian genome evolution, Curr Opin Genet Dev, 13, 651, 10.1016/j.gde.2003.10.013
Weisenberger, 2005, Analysis of repetitive element DNA methylation by MethyLight, Nucleic Acids Res, 33, 6823, 10.1093/nar/gki987
Chalitchagorn, 2004, Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis, Oncogene, 23, 8841, 10.1038/sj.onc.1208137
Iacopetta, 2007, Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa, Cancer Sci, 98, 1454, 10.1111/j.1349-7006.2007.00548.x
Sassaman, 1997, Many human L1 elements are capable of retrotransposition, Nat Genet, 16, 37, 10.1038/ng0597-37
Brouha, 2003, Hot L1s account for the bulk of retrotransposition in the human population, Proc Natl Acad Sci U S A, 100, 5280, 10.1073/pnas.0831042100
Symer, 2002, Human L1 retrotransposition is associated with genetic instability in vivo, Cell, 110, 327, 10.1016/S0092-8674(02)00839-5
Kazazian, 2002, LINE drive. retrotransposition and genome instability, Cell, 110, 277, 10.1016/S0092-8674(02)00868-1
Choma, 2001, Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data, Br J Cancer, 85, 14, 10.1054/bjoc.2001.1892
Kronenwett, 2006, Genomic instability and prognosis in breast carcinomas, Cancer Epidemiol Biomarkers Prev, 15, 1630, 10.1158/1055-9965.EPI-06-0080
Walther, 2008, Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis, Gut, 57, 941, 10.1136/gut.2007.135004
Eads, 2000, MethyLight: a high-throughput assay to measure DNA methylation, Nucleic Acids Res, 28, E32, 10.1093/nar/28.8.e32
Kawakami, 2003, The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase, Clin Cancer Res, 9, 5860
Weisenberger, 2006, CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer, Nat Genet, 38, 787, 10.1038/ng1834
R Development Core Team, 2008, R: A language and environment for statistical computing
Santourlidis, 1999, High frequency of alterations in DNA methylation in adenocarcinoma of the prostate, Prostate, 39, 166, 10.1002/(SICI)1097-0045(19990515)39:3<166::AID-PROS4>3.0.CO;2-J
Kaneda, 2004, Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation, Cancer Sci, 95, 58, 10.1111/j.1349-7006.2004.tb03171.x
Estecio, 2007, LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability, PLoS One, 2, e399, 10.1371/journal.pone.0000399
Daskalos, 2009, Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer, Int J Cancer, 124, 81, 10.1002/ijc.23849
Roman-Gomez, 2008, Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia, Leuk Res, 32, 487, 10.1016/j.leukres.2007.07.021
Menendez, 2004, L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas, Mol Cancer, 3, 12, 10.1186/1476-4598-3-12
Kawakami, 2008, Methylation level of LINE-1 repeats as a prognostic factor for the patients with primary colorectal cancer [abstract 991], Proc Am Assoc Cancer Res, 49, 232
Dombroski, 1991, Isolation of an active human transposable element, Science, 254, 1805, 10.1126/science.1662412
Mathias, 1991, Reverse transcriptase encoded by a human transposable element, Science, 254, 1808, 10.1126/science.1722352
Feng, 1996, Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition, Cell, 87, 905, 10.1016/S0092-8674(00)81997-2